NYSEARCA:IHE

Ishares Us Pharmaceuticals Etf ETF News

etoro logo Buy IHE
*Your capital is at risk
$90.02
+1.03 (+1.16%)
At Close: Jun 03, 2026
Pharma ETFs like IHE are gaining traction as drugmakers pledge $370 billion to U.S. projects, fueling a new investment super-cycle heading into 2026.
Dividend ETFs may be the best investment you can make today.
Pharma ETFs like IHE are poised to surge as the UK-US zero-tariff deal raises UK drug prices and strengthens major U.S. players' outlook.
iShares U.S. Pharmaceuticals ETF is rated a buy, driven by strong growth and dividends from top holdings like Eli Lilly, JNJ, and Merck. IHE's top holdings, particularly LLY, JNJ, and MRK, offer diver
Pharma ETFs like IHE and PPH are rallying as strong Q3 earnings across major pharmaceutical companies lift sector sentiment.
Pharma giants Eli Lily ( LLY ) and Novo Nordisk ( NVO ) have signed deals with U.S. President Donald Trump to slash the prices of some of their obesity drugs, including upcoming pills, as per a White

Pharma ETF (IHE) Hit a 52-Week High

10:01am, Wednesday, 05'th Nov 2025
Investors seeking momentum may have iShares U.S. Pharmaceuticals ETF IHE on radar now. The fund recently hit a new 52-week high.
Pharma's Trump-Pfizer boost sparks momentum, making ETFs PPH, IHE, PJP & XPH attractive for defensive, undervalued growth plays.
President Donald Trump said Thursday that he will put import taxes of 100% on pharmaceutical drugs, 50% on kitchen cabinets and bathroom vanities, 30% on upholstered furniture and 25% on heavy trucks
Trump's 100% tariff on imported drugs jolts markets, slamming pharma giants and dragging ETFs like XPH, FTXH, IHE, and PPH lower.
Looking for broad exposure to the Healthcare - Pharma segment of the equity market? You should consider the iShares U.S. Pharmaceuticals ETF (IHE), a passively managed exchange traded fund launched on
The iShares U.S. Pharmaceuticals ETF (IHE) was launched on 05/01/2006, and is a passively managed exchange traded fund designed to offer broad exposure to the Healthcare - Pharma segment of the equity

IHE: Healthcare Dashboard For June

01:24pm, Wednesday, 18'th Jun 2025
The healthcare providers industry is undervalued by about 22% versus 11-year averages, while pharma/biotech and life science tools trade near historical baseline in valuation. IHE ETF offers exposure

ETFs on the Move Post U.S.-China Trade Deal

01:55pm, Monday, 12'th May 2025
Let's delve into the ETF world following the 90-day U.S.-China trade deal.
Trump's plan to slash the price of prescription drugs by 30% put pharma ETFs in focus.
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE